Literature DB >> 31159682

Achenbach syndrome (paroxysmal finger hematoma).

Alejandro Godoy1, Aldo Hugo Tabares1,2.   

Abstract

Achenbach syndrome (paroxysmal finger hematoma) refers to a condition in which a patient exhibits episodic pain and swelling in one or more digits along with the subsequent appearance of a hematoma on the palmar side of the proximal phalanges. Achenbach syndrome is a benign condition of unknown etiology in which prodromal symptoms, such as pain, tingling, and itching, may occur from minutes to hours before the color change appears. The subdermal bleeding usually stops spontaneously or after local pressure is applied. The color changes usually disappear within a few days, without permanent sequelae. The diagnosis of Achenbach syndrome is based strictly on its clinical features because the results of all routine investigations are usually normal. Physicians should become aware of this condition in order to advise their patients about its benign prognosis and to avoid unnecessary testing.

Entities:  

Keywords:  Achenbach syndrome; blue finger; paroxysmal finger hematoma; purple digit; venous hemorrhage

Mesh:

Year:  2019        PMID: 31159682     DOI: 10.1177/1358863X19849627

Source DB:  PubMed          Journal:  Vasc Med        ISSN: 1358-863X            Impact factor:   3.239


  4 in total

1.  Achenbach's syndrome.

Authors:  João Filipe Gomes; Jorge Mendes; David Donaire; Mafalda Ferreira
Journal:  BMJ Case Rep       Date:  2020-09-07

Review 2.  Achenbach's Syndrome Revisited: The Paroxysmal Finger Hematoma May Have a Genetic Link.

Authors:  Patrick Harnarayan; Michael J Ramdass; Shariful Islam; Vijay Naraynsingh
Journal:  Vasc Health Risk Manag       Date:  2021-12-14

3.  Achenbach Syndrome: A Case Series.

Authors:  Azin Azarfar; Shazia Beg
Journal:  Cureus       Date:  2022-03-03

Review 4.  Paroxysmal Finger Hematoma-A Probable Vascular Disorder in Post-COVID-19 Condition: Two Clinical Case Presentations.

Authors:  Hristo Abrashev; Julian Ananiev; Ekaterina Georgieva
Journal:  Medicina (Kaunas)       Date:  2022-07-10       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.